Should I buy or sell Afya stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Afya in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AFYA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFYA, but not buy additional shares or sell existing shares. View AFYA analyst ratings or view top-rated stocks .

What is Afya's stock price target for 2024?

3 Wall Street analysts have issued 12-month price objectives for Afya's stock. Their AFYA share price targets range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next year. This suggests a possible upside of 36.1% from the stock's current price. View analysts price targets for AFYA or view top-rated stocks among Wall Street analysts .

How have AFYA shares performed in 2024?

Afya's stock was trading at $21.93 at the beginning of 2024. Since then, AFYA stock has decreased by 22.9% and is now trading at $16.90. View the best growth stocks for 2024 here .

Are investors shorting Afya?

Afya saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 869,400 shares, an increase of 34.5% from the March 15th total of 646,200 shares. Based on an average trading volume of 132,000 shares, the short-interest ratio is currently 6.6 days. Currently, 4.8% of the shares of the company are short sold. View Afya's Short Interest .

When is Afya's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024. View our AFYA earnings forecast .

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) released its quarterly earnings data on Thursday, March, 14th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.32 by $0.02. The firm had revenue of $147.35 million for the quarter, compared to the consensus estimate of $141.83 million. Afya had a trailing twelve-month return on equity of 15.88% and a net margin of 13.54%.

What ETFs hold Afya's stock?

ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include BNY Mellon Sustainable Global Emerging Markets ETF (BKES) . VanEck Brazil Small-Cap ETF (BRF) .

What guidance has Afya issued on next quarter's earnings?

Afya updated its FY 2024 earnings guidance on Friday, March, 15th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $635.9 million-$656.1 million, compared to the consensus revenue estimate of $633.4 million.

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE) , Cisco Systems (CSCO) , Procter & Gamble (PG) , RTX (RTX) , Abbott Laboratories (ABT) , CVS Health (CVS) , Johnson & Johnson (JNJ) , Alibaba Group (BABA) and CSX (CSX) .

Afya (AFYA) raised $233 million in an initial public offering (IPO) on Friday, July 19th 2019. The company issued 13,700,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments acted as the underwriters for the IPO.

Who are Afya's major shareholders?

Afya's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Perpetual Ltd (0.72%).

How do I buy shares of Afya?

Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:AFYA

Afya (AFYA) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free AFYA Stock Alerts

$16.90

-0.06 (-0.35%)

(As of 04/15/2024 ET)

Compare

Today's Range: $16.65
▼
$17.16
50-Day Range: $16.90
▼
$21.69
52-Week Range: $10.72
▼
$22.48

Volume: 95,270 shs
Average Volume: 127,950 shs
Market Capitalization: $1.58 billion

P/E Ratio: 19.65
Dividend Yield: N/A
Price Target: $23.00

Get Afya alerts:

Afya MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 36.1% Upside
$23.00 Price Target
Short Interest: Bearish
4.82% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.03
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 12.99%
From $1.54 to $1.74 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.87 out of 5 stars

Consumer Discretionary Sector

149th out of 260 stocks

Educational Services Industry

14th out of 20 stocks

3.0

Analyst's Opinion

Consensus Rating
Afya has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Afya has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.82% of the float of Afya has been sold short.
Short Interest Ratio / Days to Cover
Afya has a short interest ratio ("days to cover") of 6.6.
Change versus previous month
Short interest in Afya has recently increased by 34.54%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Afya does not currently pay a dividend.
Dividend Growth
Afya does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AFYA.

1.7

News and Social Media Coverage

News Sentiment
Afya has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Consumer Discretionary companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Afya this week, compared to 3 articles on an average week.
Search Interest
Only 4 people have searched for AFYA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Afya insiders have not sold or bought any company stock.
Percentage Held by Institutions
88.02% of the stock of Afya is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Afya are expected to grow by 12.99% in the coming year, from $1.54 to $1.74 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Afya is 19.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.24.
Price to Earnings Ratio vs. Sector
The P/E ratio of Afya is 19.65, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 17.47.
Price to Earnings Growth Ratio
Afya has a PEG Ratio of 0.54. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Afya has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

About Afya Stock (NASDAQ:AFYA)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

AFYA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AFYA Stock News Headlines

April 15, 2024 | msn.com

Two Tanzanians named on Forbes 30 Under 30

April 15, 2024 | msn.com

Ethiopian Jews in dire need as Israel-Hamas conflict disrupts established aid, Jewish charity says

April 16, 2024 | InvestorPlace (Ad)

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

April 12, 2024 | msn.com

Machogu Blames Uhuru's Govt for Red Flags in Public Universities

April 12, 2024 | americanbankingnews.com

Short Interest in Afya Limited (NASDAQ:AFYA) Grows By 34.5%

April 9, 2024 | msn.com

[PHOTOS] Healthcare workers stage protest in Nairobi

April 9, 2024 | msn.com

US point out gaps in Kenya's financial management system portal

April 4, 2024 | investorplace.com

AFYA Stock Earnings: Afya Beats EPS, Beats Revenue for Q4 2023

April 16, 2024 | InvestorPlace (Ad)

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

April 3, 2024 | msn.com

Kenya rolls out world's second biggest TB prevention project

April 2, 2024 | msn.com

Kenya: Let's Amplify Women Voices to Advance a Gender-Equal World

March 31, 2024 | bbc.com

Ni mafuta gani yenye afya kwa kupikia?

March 30, 2024 | msn.com

How Kenya may benefit from new pandemics treaty

March 29, 2024 | msn.com

Cholera fears as churches gather for Easter

March 26, 2024 | msn.com

KMPDU on doctors' strike: We are not scared of threats

March 22, 2024 | msn.com

Honour CBA made 7 years ago, striking doctors tell state

March 21, 2024 | msn.com

Govt Begins Deployment of 1,270 Interns Amid Pressure

March 19, 2024 | seekingalpha.com

Afya Is Performing Well And Is A Buy

March 18, 2024 | finance.yahoo.com

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

March 18, 2024 | msn.com

We will not compromise on vital issues in MoH meeting – doctors

March 16, 2024 | finance.yahoo.com

Afya Limited (NASDAQ:AFYA) Q4 2023 Earnings Call Transcript

March 15, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Afya (AFYA) and Urogen Pharma (URGN)

March 15, 2024 | msn.com

Afya Non-GAAP EPS of R$1.79, revenue of R$729.5M; initiates FY24 guidance

March 14, 2024 | businesswire.com

Afya Limited Announces Fourth Quarter and Full-Year 2023 Financial Results

March 14, 2024 | msn.com

Faulu Bank expands tailored products to empower women

March 14, 2024 | msn.com

107,831 community health workers to receive primary healthcare training

March 12, 2024 | msn.com

Strike is On, Doctors Declare as They Snub Waiguru's Request

See More Headlines

Receive AFYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Afya and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/14/2024
Today: 4/15/2024
Next Earnings (Estimated): 5/22/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Consumer Discretionary
Industry: Educational services
Sub-Industry: N/A
Current Symbol: NASDAQ:AFYA
CUSIP: N/A
CIK: 1771007
Web: www.afya.com.br
Phone: 553135157550
Fax: N/A
Employees: 8,708
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $23.00
High Stock Price Target: $23.00
Low Stock Price Target: $23.00
Potential Upside/Downside: +36.1%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.86
Trailing P/E Ratio: 19.65
Forward P/E Ratio: 10.97
P/E Growth: 0.54
Net Income: $77.38 million
Net Margins: 13.54%
Pretax Margin: 14.94%
Return on Equity: 15.88%
Return on Assets: 7.16%

Debt

Debt-to-Equity Ratio: 0.45
Current Ratio: 1.14
Quick Ratio: 1.14

Sales & Book Value

Annual Sales: $576.09 million
Price / Sales: 2.75
Cash Flow: $1.77 per share
Price / Cash Flow: 9.56
Book Value: $7.79 per share
Price / Book: 2.17

Miscellaneous

Outstanding Shares: 93,720,000
Free Float: N/A
Market Cap: $1.58 billion
Optionable: Optionable
Beta: 0.97

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Virgilio Deloy Capobianco Gibbon (Age 48)
Chief Executive Officer
Mr. Luis Andre Carpintero Blanco (Age 51)
Chief Financial Officer
Renata Couto
Investor Relations Executive Manager
Mr. Julio Eduardo Razente de Angeli (Age 51)
Vice President of Continuing Education & Innovation

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AFYA Stock Analysis - Frequently Asked Questions

Should I buy or sell Afya stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Afya in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AFYA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFYA, but not buy additional shares or sell existing shares.
View AFYA analyst ratings or view top-rated stocks.
What is Afya's stock price target for 2024?: 3 Wall Street analysts have issued 12-month price objectives for Afya's stock. Their AFYA share price targets range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next year. This suggests a possible upside of 36.1% from the stock's current price.
View analysts price targets for AFYA or view top-rated stocks among Wall Street analysts.
How have AFYA shares performed in 2024?: Afya's stock was trading at $21.93 at the beginning of 2024. Since then, AFYA stock has decreased by 22.9% and is now trading at $16.90.
View the best growth stocks for 2024 here.
Are investors shorting Afya?: Afya saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 869,400 shares, an increase of 34.5% from the March 15th total of 646,200 shares. Based on an average trading volume of 132,000 shares, the short-interest ratio is currently 6.6 days. Currently, 4.8% of the shares of the company are short sold.
View Afya's Short Interest.
When is Afya's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024.
View our AFYA earnings forecast.
How were Afya's earnings last quarter?: Afya Limited (NASDAQ:AFYA) released its quarterly earnings data on Thursday, March, 14th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.32 by $0.02. The firm had revenue of $147.35 million for the quarter, compared to the consensus estimate of $141.83 million. Afya had a trailing twelve-month return on equity of 15.88% and a net margin of 13.54%.

What ETFs hold Afya's stock?: ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include BNY Mellon Sustainable Global Emerging Markets ETF (BKES).VanEck Brazil Small-Cap ETF (BRF).
What guidance has Afya issued on next quarter's earnings?: Afya updated its FY 2024 earnings guidance on Friday, March, 15th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $635.9 million-$656.1 million, compared to the consensus revenue estimate of $633.4 million.
What other stocks do shareholders of Afya own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE), Cisco Systems (CSCO), Procter & Gamble (PG), RTX (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).
When did Afya IPO?: Afya (AFYA) raised $233 million in an initial public offering (IPO) on Friday, July 19th 2019. The company issued 13,700,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments acted as the underwriters for the IPO.
Who are Afya's major shareholders?: Afya's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Perpetual Ltd (0.72%).
How do I buy shares of Afya?: Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AFYA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Afya (AFYA) Stock Price, News & Analysis

Afya MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Afya Stock (NASDAQ:AFYA)

AFYA Stock Price History

AFYA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

AFYA Stock Analysis - Frequently Asked Questions

Overall MarketRank^™